ADC Therapeutics SA (ADCT) — Financial Flexibility Index
ADC Therapeutics SA (ADCT) has a Financial Flexibility Index of -0.06x as of March 2026. Free cash flow of $-29.68 Million (operating CF $-29.71 Million minus capex $32.00K) represents 0% of total liabilities ($507.87 Million). Check ADCT strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ADC Therapeutics SA Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for ADC Therapeutics SA across 9 annual periods. See ADC Therapeutics SA (ADCT) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for ADC Therapeutics SA (2017–2025)
Year-by-year free cash flow to debt coverage for ADC Therapeutics SA. For the full company profile including market capitalisation, see how much is ADC Therapeutics SA worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.28x | $-140.91 Million | $-141.17 Million | $508.98 Million | ▼ -18.1% |
| 2024 | -0.23x | $-122.97 Million | $-123.83 Million | $524.62 Million | ▼ -2.1% |
| 2023 | -0.23x | $-115.47 Million | $-118.69 Million | $503.03 Million | ▲ +31.4% |
| 2022 | -0.33x | $-137.62 Million | $-138.31 Million | $411.41 Million | ▲ +33.4% |
| 2021 | -0.50x | $-227.00 Million | $-233.38 Million | $451.88 Million | ▲ +46.1% |
| 2020 | -0.93x | $-165.92 Million | $-168.73 Million | $178.19 Million | ▲ +79.3% |
| 2019 | -4.50x | $-119.43 Million | $-121.58 Million | $26.53 Million | ▲ +7.9% |
| 2018 | -4.89x | $-118.89 Million | $-121.36 Million | $24.32 Million | ▼ -55.2% |
| 2017 | -3.15x | $-71.79 Million | $-74.94 Million | $22.78 Million | — |